Deal Trends In Alzheimer’s Show Promise
This article was originally published in Start Up
Executive Summary
In the wake of new funding earmarked for Alzheimer’s disease research, START-UP takes a 10-year look at Alzheimer’s dealmaking in Elsevier’s Strategic Transactions.